Estimation of cancer risks from radiotherapy of benign diseases.
Strahlenther Onkol
; 182(8): 431-6, 2006 Aug.
Article
em En
| MEDLINE
| ID: mdl-16896588
ABSTRACT
BACKGROUND:
The effective-dose method which was proposed by the ICRP (International Commission of Radiation Protection) for the estimation of risk to the general population from occupational or environmental, low-dose radiation exposure is not adequate for estimating the risk of cancer induction by radiotherapy of malignant or nonmalignant diseases.METHODS:
The risk of cancer induction by radiotherapy of benign diseases should be based on epidemiologic data directly derived from follow-up studies of patients who had been given radiotherapy for nonmalignant diseases in the past.RESULTS:
Risk factors were derived from epidemiologic studies of patients treated with irradiation for nonmalignant diseases to be used for selecting treatment options and optimizing treatment procedures.CONCLUSION:
In most cases, cancer risks estimated by the effective-dose method may overestimate the true risks by one order of magnitude, yet in other cases even may underestimate it. The proposed method using organ-specific risk factors may be more suitable for treatment planning.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Radioterapia
/
Leucemia Induzida por Radiação
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Article